Ninety-nine percent of 160 patients with different stages and types of lung cancer had high levels of HAAH in their blood, as opposed to only 9 percent of nonsmokers without lung cancer.
"It would be very valuable to have an inexpensive test to recognize that someone has an increased risk of lung cancer," said Dr. Arthur Frankel, a professor of internal medicine at Texas A&M Health Science Center College of Medicine and director of the Cancer Research Institute and the Division of Hematology/Oncology, Scott & White. "And, if you had markers that told you that if you had this marker, and you smoked, it was a bad thing, that would be very valuable. Many people are at increased risk because of genetics."
There's more on the early detection of cancer at the American Cancer Society.
SOURCES: Anthony J. Dickherber, doctoral candidate, bioengineering, Georgia Institute of Technology, Atlanta; Christopher Corso, Ph.D./M.D. student, Georgia Institute of Technology and Emory University, Atlanta; Arthur Frankel, M.D., professor, internal medicine, Texas A&M Health Science Center College of Medicine and director, Cancer Research Institute and the Division of Hematology/Oncology, Scott & White, Temple; presentations, Second International Conference on Molecular Diagnostics in Cancer Therapeutic Development, American Association for Cancer Research, Atlanta
All rights reserved